User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

7509

Interactions with Platform & by Email *

INTERACTIONS

1051

Unique # Participated *

PARTICIPANTS

225

Responses Validated *

VALIDATIONS

43

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Worldwide HIV/AIDS Testing Market – An Analysis.....II-11$100
   Regional Analysis.....II-21$100
   Segment Analysis.....II-3
HIV/AIDS Screening Tests.....II-3
HIV/AIDS Confirmatory Tests.....II-3
HIV/AIDS Monitoring Market.....II-3
1$100
   Competition.....II-4
HIV/AIDS Diagnostics Market Participants - Product Matrix.....II-4
2$200
   FDA/USAID Approved HIV Rapid Test Kits (2014).....II-61$100
   FDA-Approved Anti-HIV-1/2 and HIV-1 Antigen Combo Assays.....II-71$100
   Rapid HIV Tests – Vast Growth Potential.....II-8
Rapid Screening Tests Prevent Epidemic Spread.....II-8
1$100
   New HIV Assays to Fuel Growth.....II-9
Trends in Viral Load Testing.....II-9
Table 1: Viral Load Volumes by Region: Percentage Share of Viral Load Test Volumes for South Africa, Sub-Saharan Africa, and Rest of World (2015, 2017E, & 2019E) (includes corresponding Graph/Chart).....II-9
1$350
   Table 2: Viral Load Testing Potential by Setting: Percentage Share of Viral Load Test Volumes for District Hospitals, Large Urban Clinics, and Small Rural Clinics (2015, 2018E, & 2020E) (includes corresponding Graph/Chart).....II-10
Home Testing or Self-Testing to Gain Strength.....II-10
Self Testing: WHO Initiatives.....II-10
1$350
   Challenges Involved in Self-Testing.....II-111$100
   Drug Resistance Testing: Cornerstone for Effectiveness of Anti- Retroviral
  Therapy.....II-12
1$100
   DNA-PCR: Preferred Technique for Early Infant Diagnosis (EID).....II-131$100
   Commercial HIV Vaccines in the Pipeline.....II-14
List of Clinical Trial (Phase II) AIDS Vaccines - 2015.....II-14
1$100
   Molecular Diagnostics Register Strong Growth in Blood Screening Markets.....II-15
Emergency Room Testing to Help HIV Diagnosis.....II-15
OTC Tests Provide Momentum to HIV Testing.....II-15
1$100
   AIDS: A Global Epidemic.....II-16
Facts & Figures.....II-16
1$100
   Table 3: HIV Infection Statistics Worldwide: As of 2014 (includes corresponding Graph/Chart).....II-17

Table 4: Worldwide HIV Prevalence and Incidence (in Million) by Region: 2014 (includes corresponding Graph/Chart).....II-17
1$350
   Table 5: Worldwide AIDS related Deaths by Geographic Region: 2014 (includes corresponding Graph/Chart).....II-18

Table 6: HIV Prevalence (%) in Adults (15-49 years) by Year: Prevalence Percentage in Adults in 1990, 2000, 2008 & 2014 (includes corresponding Graph/Chart).....II-18
1$350
   Table 7: HIV Testing Service Penetration, by Region (2010-2014): Percentage Share of Adults who received HIV Testing Services in Various Global Regions (includes corresponding Graph/Chart).....II-19

Table 8: HIV Testing Services Availed, by Gender (2014): Percentage Breakdown of Women and Men in all WHO Regions (includes corresponding Graph/Chart).....II-19

Table 9: HIV-Positive Individuals, by Gender (2014): Percentage Breakdown of Women and Men Tested HIV-Positive in all WHO Regions (includes corresponding Graph/Chart).....II-19
1$350
   Table 10: International & Domestic Spending on ART in Low/Middle-Income Countries, by Region (2013): Expenditure in Millions up to 2013 (includes corresponding Graph/Chart).....II-201$350
   Table 11: No. of People on Antiviral therapy in Low/Middle-Income Countries, by Region: Numbers in 2012, 2013 & 2014 (includes corresponding Graph/Chart).....II-21
Anti-AIDS Therapeutics: A Blessing in Disguise in Developed Countries.....II-21
1$350
   Mechanism of Action.....II-221$100
   Symptoms.....II-231$100
   Full-Blown AIDS.....II-24
Transmission of HIV.....II-24
1$100
   On the Brighter Side.....II-25
HIV Therapy.....II-25
The Search Continues.....II-25
1$100
   Infection Process - Targets for HIV Therapy.....II-261$100
   Testing: The Basis for AIDS Prevention and Treatment.....II-27
Blood Processing.....II-27
The Earliest Time to Detect Infection.....II-27
1$100
   Problems Plaguing HIV Testing.....II-28
Major Drawbacks of Laboratory Diagnosis of HIV Infections.....II-28
Rapid Tests - SuiTable for Developing Countries.....II-28
1$100
   HIV Tests.....II-29
Testing Subject to Strict Rules.....II-29
Diagnostic Tests.....II-29
I. Antibody Tests.....II-29
A. HIV-1 Screening Tests.....II-29
1$100
   Test Methodology.....II-30
a. Enzyme-linked Immunosorbent Assays/ Enzyme Immunoassays (ELISA/EIA).....II-30
1$100
   b. Home Access HIV-1 test system/Dried Blood Spot.....II-311$100
   c. Rapid Tests.....II-321$100
   B. HIV-1 Antibody Confirmatory Tests.....II-33
a. The Western Blot Test.....II-33
1$100
   Commonly Used in Developed Countries.....II-34
Interpretation of Results.....II-34
1$100
   Modified Western Blots.....II-35
b. Indirect Immunofluorescent Antibody Assay (IFA).....II-35
c. Line Immunoassay.....II-35
d. Radioimmunoprecipitation Assay (RIPA).....II-35
C. HIV-2 Diagnostic Tests and HIV Group “O.....II-35
1$100
   Testing Protocols.....II-361$100
   Types of Antibody Tests Based on Sample.....II-37
i. Traditional Blood Antibody Tests.....II-37
ii. Dried Blood Spot (DBS) Sampling Technique.....II-37
iii. Other Alternatives in Samples.....II-37
Oral Testing for HIV.....II-37
1$100
   Urine Tests.....II-38
II. Viral Identification Assays.....II-38
A. p24 Antigen Test.....II-38
B. Qualitative PCR Tests.....II-38
1$100
   PCR: The Process.....II-39
C. Viral Culture.....II-39
III. Monitoring Tests.....II-39
A. Lymphocyte Analysis.....II-39
CD4 Cell Counts.....II-39
1$100
   B. Viral Load Tests.....II-40
Indicator of Successful Therapy.....II-40
1$100
   Levels of CD4 and Viral Load in AIDS.....II-41
Molecular Diagnostics and Gene Detection Products.....II-41
DNA Probe-Based Products.....II-41
Direct Assays.....II-41
Amplification.....II-41
1$100
   Amplification Methodologies.....II-42
DNA Chips.....II-42
Growth of DNA Chips Influenced by HIV Research.....II-42
Technology Review.....II-42
Home HIV Tests: Unfolding a New Era of Testing.....II-42
1$100
   PCR: A Promising Development in HIV/AIDS Monitoring Market.....II-43
DNA Probes are Highly Specific and Sensitive.....II-43
OCA-particles Based Detection System-Offers Increased Accuracy.....II-43
1$100
   Drawbacks of Blood-Based Tests.....II-44
Regulations.....II-44
Regulatory Overview.....II-44
UN’s Testing Policies in Peacekeeping Force.....II-44
1$100
   Anonymous versus Confidential Diagnostic Testing for HIV infection in US.....II-45
Regulatory Approval for Rapid HIV Test Kits in US.....II-45
HIV Testing - Mandatory in US Blood Banks.....II-45
1$100
   BioPlex® 2200 HIV Ag-Ab Assay Receives FDA Pre-market Approval.....II-46
Beckman Coulter Obtains CE Marking for DxN VERIS HIV-1 Assay.....II-46
Chembio Receives CE Mark Approval for its DPP® HIV 1/2 Assay.....II-46
BioSure UK Launches HIV Home Testing Kit.....II-46
USFDA Approves cobas® TaqScreen MPX Test by Roche Diagnostics.....II-46
Xpert® HIV-1 Viral Load Test Acquires CE-IVD Status.....II-46
1$100
   Hologic Announces CE Mark Certification for its Aptima HIV-1 Quant Dx Assay.....II-47
Bio-Rad’s Geenius™ HIV 1/2 Supplemental Assay Receives USFDA Pre-market
  Approval.....II-47
LabCorp Launches HIV GenoSure ArchiveSM Test to Optimize Drug Regimens.....II-47
DiaSorin Launches Liaison XL Murex HIV Ab/Ag High Throughput Test.....II-47
Bio-Rad Launches BioPlex 2200 HIV Ag-Ab Kit for Ex-US Markets.....II-47
MedMira Receives Approval to Market Enhanced Version of Reveal HIV Test in
  Europe.....II-47
Roche Receives CE Certification to Launch Dual target COBAS Test.....II-47
1$100
   Theradig and CNRS to Develop Theranostics HIV/AIDS Tests.....II-48
LabCorp Introduces HIV Ag/Ab Combination Assay and Screening Algorithm.....II-48
Alere Launches Rapid POC Determine HIV ½ Ag/Ag Combo Test.....II-48
1$100
   DiaSorin and Beckman Coulter Sign Distribution Partnership Agreement.....II-49
Global Initiative Lowers Price of Infant Early HIV Diagnostic Technologies.....II-49
USAID Project to Deliver HIV Testing Services in Africa.....II-49
Roche to Provide HIV-1 Viral Load and Early Infant Diagnostic Technologies for Global
  Fund.....II-49
Bio-Rad and Beckman Coulter Extend Distribution Agreement.....II-49
Case Western Reserve University Hospital Signs Agreement with Advanced Biological
  Laboratories.....II-49
1$100
   UNAIDS Collaborates with Global Partners to Launch Diagnostics Access
  Initiative.....II-50
Zyomyx Acquires $7.5 M from WHO to Market MyT4 CD4 Test in Developing World.....II-50
Daktari Diagnostics Seeks Funding for HIV Test Manufacturing Capacity.....II-50
Gilead Sciences and Good Samaritan Foundation Enter Into Partnership to Provide HIV
  Testing in Africa.....II-50
Chembio Signs Technology License, Distribution & Manufacturing Agreements with RVR
  Diagnostics SDN BHD.....II-50
Mylan Signs Exclusive Distribution Agreement with Zyomyx for POC CD4 Test.....II-50
Calypte Biomedical and Maxim Sign Joint Distribution Agreement for HIV Tests.....II-50
1$100
   Abbott Laboratories, Inc. (US).....II-51
Abbott Molecular, Inc. (US).....II-51
Adaltis S.r.l. (Italy).....II-51
1$100
   Alere (US).....II-52
Beckman Coulter, Inc. (US).....II-52
bioMérieux SA (France).....II-52
Bio-Rad Laboratories, Inc. (US).....II-52
1$100
   Calypte Biomedical Corporation (US).....II-53
Chembio Diagnostic Systems, Inc. (US).....II-53
1$100
   Hologic, Inc. (US).....II-54
Fujirebio Europe N.V. (Belgium).....II-54
MedMira Inc. (Canada).....II-54
1$100
   OraSure Technologies, Inc. (US).....II-55
Ortho-Clinical Diagnostics, Inc. (US).....II-55
Quest Diagnostics, Inc. (US).....II-55
1$100
   Roche Diagnostics (Switzerland).....II-56
Siemens Healthcare Diagnostics, Inc. (US).....II-56
1$100
   Trinity Biotech Plc. (Ireland).....II-571$100
   Unit Analytics.....II-58
Table 12: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-58
1$350
   Table 13: World Historic Review for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-591$350
   Table 14: World 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-601$350
   Table 15: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-611$350
   Table 16: World Historic Review for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-621$350
   Table 17: World 14-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-631$350
   Table 18: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-641$350
   Table 19: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-651$350
   Table 20: World 14-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-661$350
   Dollar Analytics.....II-67
Table 21: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-67
1$350
   Table 22: World Historic Review for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-681$350
   Table 23: World 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-691$350
   HIV/AIDS Testing by Test Type.....II-70
Table 24: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-70
1$350
   Table 25: World Historic Review for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-711$350
   Table 26: World 14-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-721$350
   Table 27: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-731$350
   Table 28: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-741$350
   Table 29: World 14-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-751$350
   Table 30: World Recent Past, Current & Future Analysis for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-761$350
   Table 31: World Historic Review for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-771$350
   Table 32: World 14-Year Perspective for HIV/AIDS Monitoring Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-781$350
   A. Market Analysis.....III-1
Outlook.....III-1
Government Mandates and Reimbursement Policies Aid Market Growth.....III-1
1$75
   List of Key Milestones in HIV Testing & Reimbursement.....III-2
HIV Tests Available in the US Market.....III-2
1$75
   Anti-HIV-2 Assay (to detect antibodies to Human Immunodeficiency Virus type
  2).....III-3
1$75
   Anti-HIV-1/2 Assays (to detect antibodies to Human Immunodeficiency Virus types 1
  and 2).....III-4
1$75
   FDA Approved HIV/AIDS Tests in the US Market: 2015.....III-5
Competitive Structure.....III-5
1$75
   Table 33: The US HIV POCT Market by Player (2014): Percentage Share of Sales for Chembio, OraSure Blood Tests, Orasure Saliva Tests, and Trinity (includes corresponding Graph/Chart).....III-6
Rapid HIV Tests Gain Popularity.....III-6
FDA/USAID Approved HIV Rapid Test Kits (2014).....III-6
2$200
   Home HIV Tests Abate Privacy Concerns.....III-8
NAT Tests Score High in Blood Banks.....III-8
Major End-Users of HIV/AIDS Tests.....III-8
1$75
   HIV Testing Made Mandatory in Blood Banks.....III-9
HIV/AIDS Statistics.....III-9
1$75
   Table 34: Percentage of HIV/AIDS Cases in the US, by Gender: 1993-2029 (includes corresponding Graph/Chart).....III-101$200
   Table 35: AIDS Diagnoses in the US by Ethnic Group (Through 2013): Percentage Share of AIDS Diagnosis for Blacks, Asians, Hispanics, Native Hawaiian, Native/American Indians, Whites, and Multiple Races (includes corresponding Graph/Chart).....III-11
Product Launches.....III-11
2$200
   Strategic Corporate Developments.....III-131$75
   Select Key Players.....III-144$300
   B. Market Analytics.....III-18
Unit Analytics.....III-18
Table 36: The US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-18
1$200
   Table 37: The US Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-191$200
   Table 38: The US 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-201$200
   Dollar Analytics.....III-21
Table 39: The US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-21
1$200
   Table 40: The US Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-221$200
   Table 41: The US 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Outlook.....III-24
HIV Statistics.....III-24
Table 42: Age Group Distribution of Reported HIV cases in Canada by Gender: 1985-2013 (includes corresponding Graph/Chart).....III-24
1$200
   Table 43: No. of Reported HIV Cases: 2005-2013 (includes corresponding Graph/Chart).....III-251$200
   Table 44: HIV Cases Reported in Canada by Ethnicity and Mode of Exposure (1998-2013): % Breakdown of Reported HIV cases Among different Ethnic Groups for Men who have sex with Men (MSM), Injection Drug Users (IDU), MSM/IDU, Heterosexuals, and Others (includes corresponding Graph/Chart).....III-261$200
   Table 45: HIV Diagnosis Rate in Canada by Province: 2013 (includes corresponding raph/Chart).....III-27
Medmira Inc. – A Key Player.....III-27
1$200
   B. Market Analytics.....III-28
Unit Analytics.....III-28
Table 46: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-28
1$200
   Table 47: Canadian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-291$200
   Table 48: Canadian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-301$200
   Dollar Analytics.....III-31
Table 49: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-31
1$200
   Table 50: Canadian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-321$200
   Table 51: Canadian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Table 52: HIV Occurrence in Japan by Mode of Transmission (2014): Percentage Share of HIV Transmission by Homosexual Contact, Heterosexual contact, Congenital Transmission, Intravenous Drug use, Unknown Causes, and Others (includes corresponding Graph/Chart).....III-34
1$200
   Table 53: AIDS Occurrence in Japan by Mode of Transmission (2014): Percentage Share of AIDS Transmission by Homosexual Contact, Heterosexual contact, Intravenous Drug use, Unknown Causes, and Others (includes corresponding Graph/Chart).....III-35
B. Market Analytics.....III-35
Unit Analytics.....III-35
Table 54: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-35
1$200
   Table 55: Japanese Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-361$200
   Table 56: Japanese 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-371$200
   Dollar Analytics.....III-38
Table 57: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-38
1$200
   Table 58: Japanese Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-391$200
   Table 59: Japanese 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-401$200
   A. Market Analysis.....III-41
Outlook.....III-41
Regional Analysis.....III-41
Segment Analysis.....III-41
Aids/Hiv Stats – A Review.....III-41
Western Europe.....III-41
1$75
   Table 60: HIV/AIDS Prevalence in Western Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart).....III-421$200
   Central Europe.....III-43
Table 61: HIV/AIDS Prevalence in Central Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart).....III-43
1$200
   Eastern Europe.....III-44
Table 62: HIV/AIDS Prevalence in Eastern Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart).....III-44
Regulations.....III-44
Antenatal HIV Testing in Europe.....III-44
1$200
   B. Market Analytics.....III-45
Unit Analytics.....III-45
Table 63: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-45
1$200
   Table 64: European Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-461$200
   Table 65: European 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-471$200
   Table 66: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-481$200
   Table 67: European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-491$200
   Table 68: European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-501$200
   Dollar Analytics.....III-51
Table 69: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-51
1$200
   Table 70: European Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-521$200
   Table 71: European 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-531$200
   Table 72: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-541$200
   Table 73: European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-551$200
   Table 74: European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-561$200
   A. Market Analysis.....III-57
Pharmacies Start OTC Sales of HIV Home Testing Kits.....III-57
Product Launch.....III-57
1$75
   BioMérieux SA – A Key Player.....III-58
B. Market Analytics.....III-58
Unit Analytics.....III-58
Table 75: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-58
1$200
   Table 76: French Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-591$200
   Table 77: French 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-601$200
   Dollar Analytics.....III-61
Table 78: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-61
1$200
   Table 79: French Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-621$200
   Table 80: French 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-631$200
   Market Analysis.....III-64
Market Analysis.....III-64
1$75
   Unit Analytics.....III-65
Table 81: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-65
1$200
   Table 82: German Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-661$200
   Table 83: German 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-671$200
   Dollar Analytics.....III-68
Table 84: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-68
1$200
   Table 85: German Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-691$200
   Table 86: German 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-701$200
   A. Market Analysis.....III-71
Outlook.....III-71
Table 87: HIV/AIDS Prevalence Rates by Age Group in Italy: End of 2011 (includes corresponding Graph/Chart).....III-71
1$200
   Product Launch.....III-72
Key Player – Adaltis S.R.L......III-72
1$75
   B. Market Analytics.....III-73
Unit Analytics.....III-73
Table 88: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-73
1$200
   Table 89: Italian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-741$200
   Table 90: Italian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-751$200
   Dollar Analytics.....III-76
Table 91: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-76
1$200
   Table 92: Italian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-771$200
   Table 93: Italian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-781$200
   A. Market Analysis.....III-79
Outlook.....III-79
HIV and AIDS Statistics.....III-79
1$75
   Table 94: HIV Prevalence in the UK by Mode of Transmission (2013): Number of HIV Infections Estimated in MSM, People who Inject Drugs, and Heterosexuals (includes corresponding Graph/Chart).....III-80

Table 95: HIV Prevalence in the UK in Heterosexuals (2013): Number of HIV Infections Estimated in Heterosexual Men and Women of African Ethnicity and Non-African Ethnicity (includes corresponding Graph/Chart).....III-80
1$200
   Table 96: New cases of HIV Diagnoses among Heterosexuals by Age Group (2013): Number of New HIV Infections in Heterosexuals of 15-24, 25-39, 40-49, & 50+ Age Groups (includes corresponding Graph/Chart).....III-81
Product Launch.....III-81
1$200
   B. Market Analytics.....III-82
Unit Analytics.....III-82
Table 97: The UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-82
1$200
   Table 98: The UK Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-831$200
   Table 99: The UK 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-841$200
   Dollar Analytics.....III-85
Table 100: The UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-85
1$200
   Table 101: The UK Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-861$200
   Table 102: The UK 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-871$200
   Market Analysis.....III-88
Unit Analytics.....III-88
Table 103: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-88
1$200
   Table 104: Spanish Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-891$200
   Table 105: Spanish 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-901$200
   Dollar Analytics.....III-91
Table 106: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-91
1$200
   Table 107: Spanish Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-921$200
   Table 108: Spanish 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-931$200
   A. Market Analysis.....III-94
Outlook.....III-94
Ukraine.....III-94
Austria.....III-94
Other European Countries.....III-94
1$75
   Product Launches.....III-95
Strategic Corporate Developments.....III-95
1$75
   Select Key Players.....III-961$75
   B. Market Analytics.....III-97
Unit Analytics.....III-97
Table 109: Rest of European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-97
1$200
   Table 110: Rest of European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-981$200
   Table 111: Rest of European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-991$200
   Dollar Analytics.....III-100
Table 112: Rest of European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-100
1$200
   Table 113: Rest of European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1011$200
   Table 114: Rest of European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1021$200
   A. Market Analysis.....III-103
Outlook.....III-103
The Next Epicenter for the AIDS Epidemic.....III-103
Table 115: AIDS/HIV Stats in Asia (2014).....III-103
Review of Select Asian Countries.....III-103
Australia.....III-103
1$200
   Table 116: Number of HIV and AIDS Cases in Australia: 2005 to 2011 (includes corresponding Graph/Chart).....III-1041$200
   Table 117: Number of AIDs Cases & Deaths in Australia by Age Group and Gender: End-2011 (includes corresponding Graph/Chart).....III-105
China.....III-105
AIDS/HIV – A Review.....III-105
1$200
   Efforts to Combat HIV/AIDS.....III-106
India – HIV Concentrated in South and Northeast.....III-106
Table 118: Estimated Living Population in India with HIV/AIDS Infection (2009).....III-106
1$200
   Table 119: Prevalence of TB in HIV Patients In India (2010-2013): Total No. of People Attending HIV testing centres, Diagnosed TB cases, and the percentage of HIV-Positive TB patients started on ART (includes corresponding Graph/Chart).....III-107
Thailand.....III-107
HIV Cases on Decline.....III-107
1$200
   Table 120: Number of Live Persons Infection with HIV in Thailand, by Category (2011-End): Percentage breakdown of Adult Men & Women, and Children with HIV Infection (includes corresponding Graph/Chart).....III-108
Strategic Corporate Developments.....III-108
1$200
   B. Market Analytics.....III-109
Unit Analytics.....III-109
Table 121: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-109
1$200
   Table 122: Asia-Pacific Historic Review for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1101$200
   Table 123: Asia Pacific 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1111$200
   Dollar Analytics.....III-112
Table 124: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-112
1$200
   Table 125: Asia-Pacific Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1131$200
   Table 126: Asia Pacific 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1141$200
   A. Market Analysis.....III-115
Outlook.....III-115
HIV Epidemic in Latin America.....III-115
Table 127: People Living with HIV Infection in Latin America by Country: 2011 (includes corresponding Graph/Chart).....III-115
1$200
   Trends and Transmission Modes.....III-116
Trends in Antiretroviral Treatment.....III-116
1$75
   B. Market Analytics.....III-117
Unit Analytics.....III-117
Table 128: Latin American Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-117
1$200
   Table 129: Latin American Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1181$200
   Table 130: Latin American 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1191$200
   Dollar Analytics.....III-120
Table 131: Latin American Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-120
1$200
   Table 132: Latin American Historic Review for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1211$200
   Table 133: Latin American 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1221$200
   A. Market Analysis.....III-123
Outlook.....III-123
Africa: Epicenter of the HIV Epidemic.....III-123
1$75
   Table 134: HIV/AIDS Cases in Africa as of 2011-End: Breakdown by Top 20 Countries (includes corresponding Graph/Chart).....III-1241$200
   Table 135: Adults & Children Deaths Due to AIDS in Africa (2011): Breakdown by Top 10 Countries (includes corresponding Graph/Chart).....III-125
Sub-Saharan Africa.....III-125
Table 136: AIDS/HIV Stats in Sub-Saharan Africa (2011).....III-125
Southern Africa.....III-125
1$200
   East, West and Central Africa.....III-126
South Africa – The HIV/AIDS Hub.....III-126
Uganda – A Review.....III-126
Caribbean Nations.....III-126
1$75
   Table 137: AIDS/HIV Stats in the Caribbean Nations (2011).....III-127

Table 138: HIV/AIDS Prevalence in Caribbean Nations: 2014 (includes corresponding Graph/Chart).....III-127
1$200
   Strategic Corporate Developments.....III-1281$75
   B. Market Analytics.....III-129
Unit Analytics.....III-129
Table 139: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-129
1$200
   Table 140: Rest of World Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1301$200
   Table 141: Rest of World 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1311$200
   Dollar Analytics.....III-132
Table 142: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-132
1$200
   Table 143: Rest of World Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1331$200
   Table 144: Rest of World 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1341$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com